These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1409258)

  • 1. The effects of S(-) and R(+) sulpiride, metoclopramide, cisapride and domperidone on the small intestine suggest DA2-receptors are involved in the control of small intestinal transit time in rats.
    Zuccato E; Bertolo C; Salomoni M; Forgione A; Mussini E
    Pharmacol Res; 1992 Sep; 26(2):179-85. PubMed ID: 1409258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative efficacy of some prokinetic drugs in morphine-induced gastrointestinal transit delay in mice.
    Suchitra AD; Dkhar SA; Shewade DG; Shashindran CH
    World J Gastroenterol; 2003 Apr; 9(4):779-83. PubMed ID: 12679931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine-induced protection against indomethacin-evoked intestinal lesions in rats--role of anti-intestinal motility mediated by D2 receptors.
    Miyazawa T; Matsumoto M; Kato S; Takeuchi K
    Med Sci Monit; 2003 Feb; 9(2):BR71-7. PubMed ID: 12601282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contractile mechanisms of action of gastroprokinetic agents: cisapride, metoclopramide, and domperidone.
    Orihata M; Sarna SK
    Am J Physiol; 1994 Apr; 266(4 Pt 1):G665-76. PubMed ID: 8179003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of gastrointestinal motility using the hydrogen breath test.
    Van Wyk M; Sommers DK; Steyn AG
    Br J Clin Pharmacol; 1985 Nov; 20(5):479-81. PubMed ID: 4074618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine D₂-receptor antagonists ameliorate indomethacin-induced small intestinal ulceration in mice by activating α7 nicotinic acetylcholine receptors.
    Yasuda M; Kawahara R; Hashimura H; Yamanaka N; Iimori M; Amagase K; Kato S; Takeuchi K
    J Pharmacol Sci; 2011; 116(3):274-82. PubMed ID: 21691039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-HT4 receptors are not involved in the control of small intestinal transit in the fasted conscious rat.
    Clayton NM; Gale JD
    Neurogastroenterol Motil; 1996 Mar; 8(1):1-8. PubMed ID: 8697180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cisapride or metoclopramide to accelerate small bowel transit during barium follow-through examination?
    Hare C; Halligan S; Bartram CI; Platt K; Raleigh G
    Abdom Imaging; 2000; 25(3):243-5. PubMed ID: 10823442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of serotonergic mechanisms underlying benzamide-induced gastroprokinesis.
    Linnik MD; Butler BT; Gaddis RR; Ahmed NK
    J Pharmacol Exp Ther; 1991 Nov; 259(2):501-7. PubMed ID: 1941605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of metoclopramide, domperidone, and cisapride in the management of diabetic gastroparesis.
    Brown CK; Khanderia U
    Clin Pharm; 1990 May; 9(5):357-65. PubMed ID: 2190745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of gastroduodenal coordination: dopaminergic and cholinergic pathways.
    Schuurkes JA; Van Nueten JM
    Scand J Gastroenterol Suppl; 1984; 92():8-12. PubMed ID: 6146199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic drug interactions with gastrointestinal motility modifying agents.
    Greiff JM; Rowbotham D
    Clin Pharmacokinet; 1994 Dec; 27(6):447-61. PubMed ID: 7882635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cisapride on gastrointestinal transit in healthy humans.
    Madsen JL
    Dig Dis Sci; 1990 Dec; 35(12):1500-4. PubMed ID: 2253536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute effect of the gastrokinetics cisapride and metoclopramide on the gastric emptying function in patients with the early satiety syndrome.
    Ghigliani M; Iantorno G; Vázquez S; Varela A
    Acta Gastroenterol Latinoam; 1987; 17(1):43-50. PubMed ID: 3442182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. General pharmacology of the four gastrointestinal motility stimulants bethanechol, metoclopramide, trimebutine, and cisapride.
    Megens AA; Awouters FH; Niemegeers CJ
    Arzneimittelforschung; 1991 Jun; 41(6):631-4. PubMed ID: 1930352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulatory effect of N-[4-[2-(dimethylamino)-ethoxy] benzyl]-3,4-dimethoxybenzamide hydrochloride (HSR-803) on normal and delayed gastrointestinal propulsion.
    Iwanaga Y; Miyashita N; Mizutani F; Morikawa K; Kato H; Ito Y; Itoh Z
    Jpn J Pharmacol; 1991 Jul; 56(3):261-9. PubMed ID: 1895573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of dopamine receptor subtypes in dopaminergic modulation of aldosterone secretion in rats.
    Barrett RJ; Wright KF; Taylor DR; Proakis AG
    Life Sci; 1987 Apr; 40(15):1499-506. PubMed ID: 2951574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative study on the effect of the dopamine receptor blockers metoclopramide and domperidone on stomach emptying and the visualization of the small intestine in monocontrast].
    Stellamor K; Hruby W
    Wien Klin Wochenschr; 1983 Sep; 95(18):649-52. PubMed ID: 6649651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of serotonin-3 receptor antagonist activity to gastric emptying and motor-stimulating actions of prokinetic drugs in dogs.
    Gullikson GW; Loeffler RF; Viriña MA
    J Pharmacol Exp Ther; 1991 Jul; 258(1):103-10. PubMed ID: 2072288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of prokinetic agents, cisapride and metoclopramide, on the bioavailability in humans and intestinal permeability in rats of ranitidine, and intestinal charcoal transit in rats.
    Lee HT; Lee YJ; Chung SJ; Shim CK
    Res Commun Mol Pathol Pharmacol; 2000; 108(5-6):311-23. PubMed ID: 11958284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.